BMRN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Biomarin Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 56.17 USD -3% Market Closed

Market Cap: $10.9B

	Biomarin Pharmaceutical Inc NASDAQ:BMRN	US
H	HEICO Corp NYSE:HEI.A	US
	Franchi Umberto Marmi SpA MIL:FUM	IT
	Elis SA PAR:ELIS	FR
	Barclays PLC LSE:BARC	UK
A	Amphenol Corp F:XPH	US
P	Planisware SA PAR:PLNW	FR
G	Gladstone Capital Corp NASDAQ:GLAD	US
	Indraprastha Gas Ltd NSE:IGL	IN
N	Nexon Co Ltd TSE:3659	JP
	Subsea 7 SA OSE:SUBC	UK
	Varonis Systems Inc NASDAQ:VRNS	US
	Liberty Media Corp NASDAQ:LSXMA	US
	Gateley (Holdings) PLC F:5I2	UK
P	Providence Resources PLC LSE:PVR	IE

Profitability Summary

Biomarin Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

79%

Gross Margin is Increasing

77% > 80%

Low Operating Margin

10%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

3% > 10%

Low Net Margin

Sustainable 3Y Average Net Margin

11%

Net Margin is Increasing

3% > 8%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

14%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.